Bowman J. Historical overview: hemolytic disease of the newborn. In: Kennedy MS, Wilson SM, Kelton JG, eds. Perinatal transfusion medicine. Arlington, VA: American Association of Blood Banks, 1990:1-52.Search in Google Scholar
James LS. Shock in the newborn in relation to hydrops. Ann ObstetGynecol 1971;92:599-601.Search in Google Scholar
Walker RH, ed. Technical manual. 10th ed. Arlington, VA: American Association of Blood Banks, 1990:377-410.Search in Google Scholar
Cohen F, Zuelzer WW. Mechanisms of isoimmunization. II. Transplacental passage and postnatal survival of fetal erythrocytes in heterospecific pregnancies. Blood 1967; 30:796-804.10.1182/blood.V30.6.796.796Search in Google Scholar
Lloyd LK, Miya F, Hebertson RM, et al. Intrapartum fetal bleeding in Rh negative women. ObstetGynecol 1990; 56:285-8.Search in Google Scholar
Kleihauer E, Braun H, Betke K. Demonstration von fetalem hämoglobin in den erythrozyteneinesblutauastrichs. KlinWochenschr 1957;35:637-8.10.1007/BF01481043Search in Google Scholar
Bowman JM, Pollack JM, Pension LE. Fetomatemaltranspla-cental hemorrhage during pregnancy and after delivery. Vox Sang 1986;51:117-21.10.1111/j.1423-0410.1986.tb00226.xSearch in Google Scholar
Warren RC, Butler J, Morsman JM, et al. Does chorionic villus sampling cause FMH? Lancet 1985;1:691.10.1016/S0140-6736(85)91345-5Search in Google Scholar
Levine P. The influence of the ABO system on Rh hemolytic disease. Hum Biol 1958;30:14–28.Search in Google Scholar
Race RR, Sanger R. Blood groups in man. Oxford: Scientific Publications, 1950.Search in Google Scholar
Stern K, Goodman HS, Berger M. Experimental isoimmunization to hemoantigens in man. J Immunol 1961; 87:189-98.10.1007/978-94-011-6138-1_28Search in Google Scholar
Woodrow JC, Donohue WTA. Rh immunization by pregnancy: results of a survey and their relevance to prophylactic therapy. BrMedJ 1968;4:139-44.Search in Google Scholar
Ascari WQ, Levine P, Pollack W. Incidence of maternal Rh immunization by ABO compatible and incompatible pregnancies. Br Med J 1969;1:399-401.10.1136/bmj.1.5641.39919818914179167Search in Google Scholar
Freda VJ, Gorman JG, Pollack W. Successful prevention of experimental Rh sensitization in man with an anti-Rh gamma 2-globulin antibody preparation: a preliminary report. Transfusion 1964;4:26-32.10.1111/j.1537-2995.1964.tb02824.x14105934Search in Google Scholar
Zipursky A, Israels LG. The pathogenesis and prevention of Rh immunization. Can Med Assoc J 1967;97:1245-57.10.1007/978-94-011-6138-1_40Search in Google Scholar
Combined Study. Prevention of Rh-haemolytic disease. Br MedJ 1966;2:901-14.10.1136/bmj.2.5519.901Search in Google Scholar
Clarke CA, Donohoe WTA, McConnell RB, et al. Further experimental studies in the prevention of Rh-haemolytic disease. Br Med J 1963;1:979-84.10.1136/bmj.1.5336.979212288814021558Search in Google Scholar
Chown B, Duff AM, James J, et al. Prevention of primary Rh immunization: first report of the Western Canadian trial, 1966-1968. Can Med Assoc J 1969;100:1021-4.Search in Google Scholar
Bowman JM, Chown B, Lewis M, et al. Rh-isoimmunization during pregnancy: antenatal prophylaxis. Can Med Assoc J 1978;118:623-7.Search in Google Scholar
Wenk RE, Goldstein P, Felix JK. Alloimmunization by hr’(c), hemolytic disease of newborns, and perinatal management.ObstetGynecol 1986;67:623-6.Search in Google Scholar
Powell PJ, Brown SE, Dike AE, Inskip MJ. The significance of anti-c alloimmunization in pregnancy. Br J Obstet Gynecol 1986;93:1044-8.10.1111/j.1471-0528.1986.tb07829.xSearch in Google Scholar
Farr V, Gray E. Pregnancy outcome in mothers who develop Kell antibodies. Scot Med J 1988;33:300-3.10.1177/003693308803300407Search in Google Scholar
Biermé SJ, Blane M, Abbal M, et al. Oral Rh treatment for severely immunized mothers. Lancet 1979;1:604–5.10.1016/S0140-6736(79)91024-9Search in Google Scholar
Barnes RMR, Duguid JKM, Roberts FM, et al. Oral administration of erythrocyte membrane antigen does not suppress anti-Rh(D) antibody responses in humans. Clin Exp Immunol 1987;67:220-6.Search in Google Scholar
Carter BB. Preliminary report on a substance which inhibits anti-Rh serum. Am J ClinPathol 1947;17:646-9.10.1093/ajcp/17.8.646Search in Google Scholar
Gusdon JP, Caudle MR, Herbst GA, Iannuzzi NP. Phagocytosis and erythroblastosis: I. Modification of the neonatal response by promethazine hydrochloride. Am J ObstetGynecol 1976;125:224-6.10.1016/0002-9378(76)90597-4Search in Google Scholar
Bowman JM, Pollock JM. Reversal of Rh alloimmunization. Fact or fancy? Vox Sang 1984;47:209-15.Search in Google Scholar
De Silva M, Contreras M, Mollison PL. Failure of passively administered anti-Rh to prevent secondary Rh immune responses. Vox Sang 1985;48:178-80.10.1111/j.1423-0410.1985.tb00167.xSearch in Google Scholar
Graham-Pole J, Barr W, Willoughby MLN. Continuous flow plasmapheresis in management of severe Rhesus disease. Br MedJ 1977;1:1185-8.10.1136/bmj.1.6070.1185Search in Google Scholar
Robinson EAE, Tovey LAD. Intensive plasma exchange in the management of severe Rh disease. Br J Haematol 1980;45:621-31.10.1111/j.1365-2141.1980.tb07185.xSearch in Google Scholar
Berlin G, Selbing A, Ryden G. Rhesus haemolytic disease treated with high-dose intravenous immunoglobulin (letter). Lancet 1985;1:1153.10.1016/S0140-6736(85)92451-1Search in Google Scholar
de la Camara C, Arrieta R, Gonzalez A, et al. High-dose intravenous immunoglobulin as the sole prenatal treatment for severe Rh immunization. N Engl J Med 1988;318:519-20.10.1056/NEJM1988022531808163123931Search in Google Scholar
Tabb PA, Inglis J, Savage DCL, Walker CHM. Controlled trial of phototherapy of limited duration in the treatment of physiological hyperbilirubinemia in low-birth-weight infants. Lancet 1972;2:1211.10.1016/S0140-6736(72)92265-9Search in Google Scholar
Hill RM, Meza GC. Utilization of blood components in neonatal medicine. In: Bell CA, ed. A seminar on perinatal blood banking. Washington, DC: American Association of Blood Banks, 1978:109-30.Search in Google Scholar
Judd WJ, Luban NLC, Ness PM, et al. Prenatal and perinatal immunohematology: recommendations for serologic management of the fetus, newborn infant, and obstetric patient. Transfusion 1990;30:175-83.10.1046/j.1537-2995.1990.30290162907.xSearch in Google Scholar
Widmann FK, ed. Standards for blood banks and transfusion services. 14th ed. Arlington, VA: American Association of Blood Banks, 1991.Search in Google Scholar
Pollack W, Ascari WQ, Kockesky RJ, et al. Studies on Rh prophylaxis: I. Relationship between doses of anti-Rh and size of antigenic stimulus. Transfusion 1971;11:333-9.10.1111/j.1537-2995.1971.tb04424.xSearch in Google Scholar
Rivat L, Parent M, Rivat C. Accident survenuaprés injection de gamma-globulines anti-Rh du à la présence d’anticorps anti-IgA (letter). Press Med 1970;78:2072.Search in Google Scholar
Bowman JM, Friesen AD, Pollock JM, et al. WinRho: Rh immune globulin prepared by ion exchange for intravenous use. Can Med Assoc J 1980;123:1121-5.Search in Google Scholar
Crawford DH, Barlow MJ, Harrison JF, et al. Production of human monoclonal antibody to rhesus D antigen. Lancet 1983;1:386-8.10.1016/S0140-6736(83)91502-7Search in Google Scholar
Bron D, Feinberg MB, Teng NNH, et al. Production of human monoclonalIgG antibodies against rhesus (D) antigen. Proc Natl Acad Sci (USA) 1984;81:3214-7.10.1073/pnas.81.10.32143452526427767Search in Google Scholar
Kennedy MS, Wilson SM, Kelton JG, eds. Perinatal transfusion medicine. Arlington, VA: American Association of Blood Banks, 1990.Search in Google Scholar
